Published Online: Monday, January 1, 2007

The introduction of drug pedigrees has been delayed after a federal court agreed to grant an injunction. The court made its ruling after a number of drug wholesalers requested the postponement. The wholesalers claimed the mandate would bankrupt them because they would not be able to meet the requirement.

The rule, which was to go into effect last month, required anyone involved in the wholesale distribution of a drug, who is not the manufacturer or an authorized distributor of record, to document every individual or company that handles that drug. The government wanted to enforce drug pedigrees in an effort to lower the rate of counterfeit drugs. The pedigrees would track the drugs from a manufacturing plant to a retail pharmacy.

"I think this will likely be a time for the industry to wait and see what the FDA's response [to the injunction] is," responded Diane Darvey, directory of pharmacy regulatory affairs for the National Association of Chain Drug Stores.

Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues